How to use the speech recognition tool?

EudraCT 2016-003705-34

PIGMENT – PDE6A gene therapy for retinitis pigmentosa

PIGMENT – PDE6A gene therapy for retinitis pigmentosa.

Type: Interventional

Status of the trial: Active, Recruiting

Orphan Drug Recognition: Yes


  • Opening Date: 2019-07-02
  • Closing Date: 0000-00-00


More information

Children: No

Adults: Yes

Funder Type: national institution

HCP: Other investigators

Within ERN-EYE members

Principal investigators

Other investigators


  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: